z-logo
open-access-imgOpen Access
Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
Author(s) -
Ashwin Dharmadhikari,
Mohan G. Kabadi,
Bob Gerety,
Anthony J. R. Hickey,
P. Bernard Fourie,
Edward A. Nardell
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xtq2-2z49
Subject(s) - capreomycin , tuberculosis , drug , medicine , pharmacology , dry powder inhaler , mycobacterium tuberculosis , pathology , asthma , ethambutol , inhaler

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here